These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3311456

  • 1. Elevated pulmonary vascular resistance and cardiac transplantation.
    Addonizio LJ, Gersony WM, Robbins RC, Drusin RE, Smith CR, Reison DS, Reemtsma K, Rose EA.
    Circulation; 1987 Nov; 76(5 Pt 2):V52-5. PubMed ID: 3311456
    [Abstract] [Full Text] [Related]

  • 2. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H, Haraldsson A, Ricksten SE, Kjellman U, Wiklund L.
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation.
    Zales VR, Pahl E, Backer CL, Crawford S, Mavroudis C, Benson DW.
    J Heart Lung Transplant; 1993 Jun; 12(6 Pt 1):965-72; discussion 972-3. PubMed ID: 8312321
    [Abstract] [Full Text] [Related]

  • 4. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 5. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year.
    Chau EM, Bailey KR, Mahoney DW, Frantz RP, McGregor CG, Daly RC, Edwards BS, Olson LJ, Rodeheffer RJ.
    Circulation; 1996 Nov 01; 94(9 Suppl):II267-72. PubMed ID: 8901758
    [Abstract] [Full Text] [Related]

  • 6. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
    Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE.
    J Thorac Cardiovasc Surg; 1991 Mar 01; 101(3):432-44; discussion 444-5. PubMed ID: 1999936
    [Abstract] [Full Text] [Related]

  • 7. What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation.
    Chiu P, Russo MJ, Davies RR, Addonizio LJ, Richmond ME, Chen JM.
    J Heart Lung Transplant; 2012 Jan 01; 31(1):61-6. PubMed ID: 22019236
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B, Naegele H, Mohacsi P, Trautnitz M, PROPHET Study Group.
    J Heart Lung Transplant; 2006 Sep 01; 25(9):1070-6. PubMed ID: 16962468
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L, Grimm M, Rajek A, Wolner E, Wieselthaler G.
    J Thorac Cardiovasc Surg; 2007 Mar 01; 133(3):689-95. PubMed ID: 17320566
    [Abstract] [Full Text] [Related]

  • 10. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
    Klotz S, Wenzelburger F, Stypmann J, Welp H, Drees G, Schmid C, Scheld HH.
    Ann Thorac Surg; 2006 Nov 01; 82(5):1770-3. PubMed ID: 17062245
    [Abstract] [Full Text] [Related]

  • 11. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure.
    Mitchell MB, Campbell DN, Ivy D, Boucek MM, Sondheimer HM, Pietra B, Das BB, Coll JR.
    J Thorac Cardiovasc Surg; 2004 Nov 01; 128(5):693-702. PubMed ID: 15514596
    [Abstract] [Full Text] [Related]

  • 12. Cardiac transplant recipients with preoperative pulmonary hypertension. Evolution of pulmonary hemodynamics and surgical options.
    Kawaguchi A, Gandjbakhch I, Pavie A, Bors V, Muneretto C, Leger P, Mestiri T, Piazza C, Cabrol A, Desruennes M.
    Circulation; 1989 Nov 01; 80(5 Pt 2):III90-6. PubMed ID: 2805309
    [Abstract] [Full Text] [Related]

  • 13. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
    Gorlitzer M, Ankersmit J, Fiegl N, Meinhart J, Lanzenberger M, Unal K, Dunkler D, Kilo J, Wolner E, Grimm M, Grabenwoeger M.
    Transpl Int; 2005 Apr 01; 18(4):390-5. PubMed ID: 15773956
    [Abstract] [Full Text] [Related]

  • 14. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study.
    Martin J, Siegenthaler MP, Friesewinkel O, Fader T, van de Loo A, Trummer G, Berchtold-Herz M, Beyersdorf F.
    Eur J Cardiothorac Surg; 2004 Jun 01; 25(6):971-7. PubMed ID: 15144997
    [Abstract] [Full Text] [Related]

  • 15. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Kieler-Jensen N, Ricksten SE, Stenqvist O, Bergh CH, Lindelöv B, Wennmalm A, Waagstein F, Lundin S.
    J Heart Lung Transplant; 1994 Jun 01; 13(3):366-75. PubMed ID: 8061011
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation.
    Iberer F, Wasler A, Tscheliessnigg K, Petutschnigg B, Auer T, Müller H, Rödl S.
    J Heart Lung Transplant; 1993 Jun 01; 12(2):173-8. PubMed ID: 8476887
    [Abstract] [Full Text] [Related]

  • 17. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P, Parry G, Dark JH, Macgowan GA.
    J Heart Lung Transplant; 2009 Jul 01; 28(7):676-82. PubMed ID: 19560695
    [Abstract] [Full Text] [Related]

  • 18. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
    Fojón S, Fernández-González C, Sánchez-Andrade J, López-Pérez JM, Hermida LF, Rodríguez JA, Juffé A.
    Transplant Proc; 2005 Nov 01; 37(9):4028-30. PubMed ID: 16386617
    [Abstract] [Full Text] [Related]

  • 19. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.
    Chang PP, Longenecker JC, Wang NY, Baughman KL, Conte JV, Hare JM, Kasper EK.
    J Heart Lung Transplant; 2005 Aug 01; 24(8):998-1007. PubMed ID: 16102433
    [Abstract] [Full Text] [Related]

  • 20. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM, Dembitsky WP, Jaski BE, Daily PO, Moreno R, Kim JC, Sono J, Akasaka T, Hoagland PM, Gordon JB.
    ASAIO J; 1997 Aug 01; 43(4):365-9. PubMed ID: 9242955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.